2022
DOI: 10.1080/17460441.2022.2114451
|View full text |Cite
|
Sign up to set email alerts
|

Designing drugs when there is low data availability: one-shot learning and other approaches to face the issues of a long-term concern

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 218 publications
0
7
0
Order By: Relevance
“…In the future, deep learning models, by learning and generalizing across feature representations, hold the promise of enhancing predictive accuracy and broadening the scope of data analysis in the study of cardiotoxicity. Further, a recurring challenge in using comprehensive -omics data is the sparsity of data, which limits prospective validation . This necessitates the development of models that can make reliable predictions even with sparse or incomplete data sets.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In the future, deep learning models, by learning and generalizing across feature representations, hold the promise of enhancing predictive accuracy and broadening the scope of data analysis in the study of cardiotoxicity. Further, a recurring challenge in using comprehensive -omics data is the sparsity of data, which limits prospective validation . This necessitates the development of models that can make reliable predictions even with sparse or incomplete data sets.…”
Section: Resultsmentioning
confidence: 99%
“…Further, a recurring challenge in using comprehensive -omics data is the sparsity of data, which limits prospective validation. 88 This necessitates the development of models that can make reliable predictions even with sparse or incomplete data sets. In this study, we observed that models based on computed physicochemical properties performed on par with other ensemble models.…”
Section: Resultsmentioning
confidence: 99%
“…In summary, those observations could be very useful in the design of novel cytotoxic compounds with potential anticancer application. Since all compounds share structural similarity and the biological data were obtained without interlaboratory interference, despite the low number of samples the obtained information is highly valuable for drug design campaigns [18] …”
Section: Resultsmentioning
confidence: 99%
“…Since all compounds share structural similarity and the biological data were obtained without interlaboratory interference, despite the low number of samples the obtained information is highly valuable for drug design campaigns. [18]…”
Section: Computational Studiesmentioning
confidence: 99%
“…Examples include "Small Data Set QSAR Modeling," which finds predictive models by using exhaustive cross-validation across different https://doi.org/10.26434/chemrxiv-2022-dct7l-v3 ORCID: https://orcid.org/0000-0001-9675-5907 Content not peer-reviewed by ChemRxiv. License: CC BY-NC-ND 4.0 sampling replicates, oversampling strategies, and the use of other machine learning methods based on transfer and few-shot learning [59][60][61].…”
Section: Validation Of Qsar Modelsmentioning
confidence: 99%